Precision Interdiction of α-Synuclein Folding Pathways by Molecular Tweezers
Madhusmita Devi1, Sandip Paul1
1Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039 Assam, India.
None:
The misfolding of α-synuclein (α-Syn) is a pivotal event in the degeneration of dopaminergic neurons and the progression of Parkinson's disease. Given its pathological significance, elucidating the self-assembly of α-Syn and developing inhibitors that suppress aberrant misfolding are imperative for effective synucleinopathy therapies. Building upon the remarkable potential of Whitlock's caffeine-armed molecular tweezer in inhibiting amyloid-β aggregation, this study employs all-atom MD simulations under NPT conditions to explore its impact on α-Syn misfolding. Analyses of the secondary structure and cluster conformations reveal a global transition of the N-terminal and NAC regions into largely unstructured conformations interspersed with multiple β-sheet formations spanning both regions. The simulations further capture the emergence of a β-hairpin structure spanning residues 38-53, a region previously identified as the primary nucleation site for aggregation. Notably, the introduction of the caffeine-tweezers significantly reduces the formation of ordered β-sheet structures. Contact maps, free-energy landscapes, and binding evaluations collectively demonstrate a strong binding preference of the tweezer for the N- and C-terminal regions of the peptide. By engaging in π-stacking interactions with aromatic residues at the termini, the tweezer induces a looped conformation that disrupts non-native contacts between the N-terminus and the NAC segment. This rearrangement restores native long-range interactions between the terminal domains, thereby re-establishing the protein's intrinsic regulatory mechanism that suppresses NAC-mediated pathological aggregation. These findings elucidate the inhibitory role of the caffeine-tweezer, underscoring its therapeutic potential in targeting α-Syn misfolding. Our findings offer a rational framework for the design of novel therapeutics combating synucleinopathies.
Related Concept Videos
Protein Folding
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...


